To further assess the relative leukemia burden at the primary sites of leukemia replication such as bone marrow and spleen, we quantified the number of luciferase-tagged BCR-ABL cells in the bone marrow (Supplementary Fig. S6A). This evidence concerns the gene ABL1 and leukemia.